Bhuwanatala Indah Permai Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bhuwanatala Indah Permai Tbk. trades at Rp70 (market cap 316.81B, 265.26M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Bhuwanatala Indah Permai Tbk. and Diagnos Laboratorium Utama Tbk. are close in size by market cap, and Bhuwanatala Indah Permai Tbk. is more actively traded (265.26M versus 159.2K). Which is the better fit depends on your goals.
| BIPP | DGNS | |
|---|---|---|
Market Cap | 316.81B | 310.75B |
Volume | 265.26M | 159.2K |
Lot | 2.65M | 1.59K |
Turnover | 19.02B | 34.72M |
Average Price | 71.72 | 218.06 |
Value | 19.02B | 34.72M |
Indicative Equilibrium Price | 70 | 220 |
Indicative Equilibrium Volume | 20.2K | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bhuwanatala Indah Permai Tbk (the Company) was initially established within the framework of Domestic Capital Investment Law No. 6 year 1968 as amended by law No. 12 year 1970 based on Notarial Deed No. 165 dated December 21, 1981 of Public Notary Koswara, S.H. PT Bhuwanatala operates in hotel management, retail properties, and office space. The company listed its shares on Over-The Counter Market, and since the merger of the OTC Market with the Surabaya Stock Exchange, the shares automatically listed on the SSX.
Read more on BIPP →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →